Related Experiment Video
Updated: May 27, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
[Multidrug resistant tuberculosis -- its extent, hazard and possible solutions]
1Centre de Compétence Tuberculose, Ligue Pulmonaire Suisse, 14c, Südbahnhofstrasse, 3000 Berne 14, Suisse. zellwegerjp@swissonline.ch
Revue Des Maladies Respiratoires
|November 22, 2011
Summary
Multidrug-resistant tuberculosis (MDR-TB) is a global threat. Combating MDR-TB requires rapid identification of resistant strains and careful drug management to prevent untreatable cases.
Area of Science:
- Microbiology
- Public Health
- Genetics
Context:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge, threatening the efficacy of tuberculosis control programs worldwide.
- The emergence of extensively drug-resistant tuberculosis (XDR-TB) presents nearly untreatable cases, exacerbating the public health crisis.
- MDR-TB arises from management errors that promote drug-resistant strains, necessitating urgent intervention strategies.
Purpose:
- To outline current strategies for identifying and managing MDR-TB.
- To emphasize the critical role of public health measures in preventing the development and spread of MDR-TB.
- To highlight the need for adapting national tuberculosis control strategies to address MDR-TB.
Summary:
- Current MDR-TB management involves rapid molecular identification of resistant strains and judicious use of second-line drugs.
- Public health interventions focused on preventing the selection and transmission of resistant strains are paramount.
- Addressing the development and spread of MDR-TB is crucial for the future success of global tuberculosis eradication efforts.
Impact:
- Successful implementation of these strategies can curb the rise of untreatable tuberculosis strains.
- National tuberculosis programs must evolve to incorporate effective MDR-TB prevention and control measures.
- Enhanced global collaboration and resource allocation are vital to combat the escalating threat of MDR-TB.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...